We are sorry, but NCBI web applications do not support your browser, and may not function properly. More information here...
My NCBISign In
Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
Thomas Frogne, Anne-Vibeke Laenkholm, Maria B Lyng, Katrine Lütken Henriksen, Anne E Lykkesfeldt
Breast Cancer Res. 2009; 11(1): R11. Published online 2009 February 24. doi: 10.1186/bcr2230
PMCID:
PMC2687716
Abstract Full Text PDF–1.7M

Is Cited by the Following 13 Articles in this Archive:

Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study
Maria B. Lyng, Anne-Vibeke Lænkholm, Rolf Søkilde, Karina H. Gravgaard, Thomas Litman, Henrik J. Ditzel
PLoS One. 2012; 7(5): e36170. Published online 2012 May 18. doi: 10.1371/journal.pone.0036170
PMCID:
PMC3356496
Abstract Full Text PDF–218K Supplementary Material
Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer
Naoki Hayashi, Takayuki Iwamoto, Ana M. Gonzalez-Angulo, Jaime Ferrer-Lozano, Ana Lluch, Naoki Niikura, Chandra Bartholomeusz, Seigo Nakamura, Gabriel N. Hortobagyi, Naoto T. Ueno
Oncologist. 2011 July; 16(7): 956–965. Published online 2011 June 28. doi: 10.1634/theoncologist.2010-0409
PMCID:
PMC3228141
Free in PMC on 2012/07/01
Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action
Lisa DeFazio-Eli, Kristi Strommen, Trang Dao-Pick, Gordon Parry, Laurie Goodman, John Winslow
Breast Cancer Res. 2011; 13(2): R44. Published online 2011 April 15. doi: 10.1186/bcr2866
PMCID:
PMC3219207
Abstract Full Text PDF–844K Supplementary Material
Long-term cultures of stem/progenitor cells from lobular and ductal breast carcinomas under non-adherent conditions
Agostina Nardone, Sara Corvigno, Annalisa Brescia, Daniel D’Andrea, Gennaro Limite, Bianca Maria Veneziani
Cytotechnology. 2011 January; 63(1): 67–80. Published online 2010 December 28. doi: 10.1007/s10616-010-9328-3
PMCID:
PMC3021146
Abstract Full Text PDF–715K
µFBI: A Microfluidic Bead-Based Immunoassay for Multiplexed Detection of Proteins from a µL Sample Volume
Xiaobo Yu, Michael Hartmann, Quan Wang, Oliver Poetz, Nicole Schneiderhan-Marra, Dieter Stoll, Cornelia Kazmaier, Thomas O. Joos
PLoS One. 2010; 5(10): e13125. Published online 2010 October 1. doi: 10.1371/journal.pone.0013125
PMCID:
PMC2948516
Abstract Full Text PDF–1.5M
Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer
Isabel F Pinhel, Fiona A MacNeill, Margaret J Hills, Janine Salter, Simone Detre, Roger A'Hern, Ashutosh Nerurkar, Peter Osin, Ian E Smith, Mitch Dowsett
Breast Cancer Res. 2010; 12(5): R76. Published online 2010 September 28. doi: 10.1186/bcr2719
PMCID:
PMC3096968
Abstract Full Text PDF–867K
Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
M F E Godinho, A M Sieuwerts, M P Look, D Meijer, J A Foekens, L C J Dorssers, T van Agthoven
Br J Cancer. 2010 October 12; 103(8): 1284–1291. Published online 2010 September 21. doi: 10.1038/sj.bjc.6605884
PMCID:
PMC2967058
Abstract Full Text PDF–515K Supplementary Material
Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study
C A Purdie, L Baker, A Ashfield, S Chatterjee, L B Jordan, P Quinlan, D J A Adamson, J A Dewar, A M Thompson
Br J Cancer. 2010 August 10; 103(4): 475–481. Published online 2010 July 27. doi: 10.1038/sj.bjc.6605799
PMCID:
PMC2939790
Abstract Full Text PDF–427K Supplementary Material
Assay Development for the Determination of Phosphorylation Stoichiometry using MRM methods with and without Phosphatase Treatment: Application to Breast Cancer Signaling Pathways
Dominik Domanski, Leigh C. Murphy, Christoph H. Borchers
Anal Chem. Author manuscript; available in PMC 2011 July 1.
Published in final edited form as: Anal Chem. 2010 July 1; 82(13): 5610–5620. doi: 10.1021/ac1005553
PMCID:
PMC2909760
Abstract Full Text PDF–1.9M
Human Prostatic Acid Phosphatase, an Authentic Tyrosine Phosphatase, Dephosphorylates ErbB-2 and Regulates Prostate Cancer Cell Growth
Tsai-Der Chuang, Siu-Ju Chen, Fen-Fen Lin, Suresh Veeramani, Satyendra Kumar, Surinder K. Batra, Yaping Tu, Ming-Fong Lin
J Biol Chem. 2010 July 30; 285(31): 23598–23606. Published online 2010 May 24. doi: 10.1074/jbc.M109.098301
PMCID:
PMC2911278
Abstract Full Text Supplementary Material
Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer
I H Koumakpayi, C Le Page, A-M Mes-Masson, F Saad
Br J Cancer. 2010 March 30; 102(7): 1163–1173. Published online 2010 March 9. doi: 10.1038/sj.bjc.6605571
PMCID:
PMC2853085
Abstract Full Text PDF–967K Supplementary Material
Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response
Ramaswamy Bhuvaneswari, Yik Yuen Gan, Khee Chee Soo, Malini Olivo
Mol Cancer. 2009; 8: 94. Published online 2009 November 2. doi: 10.1186/1476-4598-8-94
PMCID:
PMC2777152
Abstract Full Text PDF–2.5M
NRG1/ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation
Kristina Buac, Mai Xu, Julie Cronin, Ashani T. Weeraratna, Stephen M. Hewitt, William J. Pavan
Pigment Cell Melanoma Res. Author manuscript; available in PMC 2011 January 19.
Published in final edited form as: Pigment Cell Melanoma Res. 2009 December; 22(6): 773–784. Published online 2009 July 30. doi: 10.1111/j.1755-148X.2009.00616.x
PMCID:
PMC3023175
Abstract Full Text PDF–1.4M Supplementary Material
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk